APOE and Alzheimer disease: High dose (40 IU) improved visuospatial and verbal working memory for all participantHigh dose improved memory for adults with MCI and AD who were APOE-ε 4 positive patientsAPOE-ε 4 carriers taking high dose also improved peripheral insulin resistanceAPOE-ε 4 negative patients taking high dose experiences increased peripheral insulin resistance